Associate Director, Commercial Regulatory Affairs Revolution Medicines IncAssociate Director, Commercial Regulatory AffairsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As part of the Regulatory Affairs function, the Associate Director will work under supervision to provide strategic regulatory advice on advertising/promotion and medical materials to the US organization for assigned products in accordance with business goals and objectives, FDA regulations/guidances, pharma guidelines, and company policy.
Senior Director, Executive & Enterprise Communications Revolution Medicines IncSenior Director, Executive & Enterprise CommunicationsRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: The Senior Director, Executive & Enterprise Communications will serve as a trusted communications advisor to the CEO and select senior leaders while leading enterprise internal communications across a growing global organization.
Director, Stability Management, Analytical Development and Quality Control Revolution Medicines IncDirector, Stability Management, Analytical Development and Quality ControlRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Collaborate cross-functionally with teams in drug substance, drug product, supply chain, quality, regulatory, sourcing and other related team to ensure alignment of stability design and achieve stability study objectives.
Senior Director, Organic Social Lewis PR IncSenior Director, Organic SocialSan Francisco, CA$120,000–$160,000 / yearIts success is due to a combination of factors: its ability to read the future and prepare for it; leveraging cutting edge AI; strategic thinkers delivering award winning campaigns; expanding client relationships into new markets or services; and above all, independence from outside investors. You will serve as a day-to-day senior client lead for social, partner closely with creative and paid media teams, and work with analysts to translate performance signals into clear actions that improve outcomes and expand account value.
NewSenior Medical Director Oncology Clinical Development Solid Tumors AbbVie IncSenior Medical Director Oncology Clinical Development Solid TumorsSouth San Francisco, CAActs as a clinical interface and actively solicits opinion leader interactions related to the molecule and disease area; partners with Medical Affairs, Commercial and other functions in these activities as required, consistent with corporate policies, to ensure that broad cross-functional perspectives are incorporated into Clinical Development Plans and protocols as appropriate. Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law: The compensation range described below is the range of possible base pay compensation that the Company believes in good faith it will pay for this role at the time of this posting based on the job grade for this position.
Senior Medical Director, Early-Stage Clinical Development Revolution Medicines IncSenior Medical Director, Early-Stage Clinical DevelopmentRedwood City, CA$346,000–$397,000 / yearHas demonstrated collaborative behaviors on enterprise-level strategic initiatives with a variety of internal and external partners and stakeholders - including clinical investigators/clinicians, scientists and key opinion leaders (KOLs), as well as internal groups, including other groups in development, research, business development, commercial, legal, etc. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director Program Management Abbott LaboratoriesDirector Program ManagementSanta Clara, CA$149,300–$298,700 / yearThe Director Program Management provides overall leadership, direction and co-ordination to the Abbott New Zealand integration project team, maintaining awareness for the need for on-going change and continuous improvement, monitoring performance versus project milestones and timelines and taking corrective action as necessary to meet targets for project completion schedule, budgets and start up. Provides on-going updates to key leaders in Division, Corporate and other support groups including the Project Steering Committee, Program Management team, Commercial, and functional leadership.
Director, US Strategic Pricing, Pipeline Revolution MedicinesDirector, US Strategic Pricing, PipelineRedwood City, California$211,000–$264,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Effectively partner with internal stakeholders to develop relationships to drive price strategy access including Global Market Access, Pricing, and Development, US Market Access Marketing, Field Key Account teams.
Executive Director, IT Vendor Management Hewlett Packard EnterpriseExecutive Director, IT Vendor ManagementSan Jose, CA$196,000–$429,000 / yearJob Description: Primary Responsibilities: Software Spend Audit and Cost Takeout: Own a comprehensive audit of HPE's global IT software portfolio across all SaaS subscriptions, on-premises licenses, maintenance agreements, and acquired-entity software obligations, establishing a total cost of ownership baseline within 90 days. Telecommunications Cost Rationalization: Own commercial oversight of all HPE enterprise telecommunications obligations including network services, voice and data contracts, carrier agreements, colocation, and connectivity at the enterprise and site level.
Director of Revenue Operations Dealpath IncDirector of Revenue OperationsSan Francisco, CA$155,000–$220,000 / yearBy bringing together the only private exchange for institutional real estate listings, investment data, and intelligent execution workflows into a single platform, Dealpath enables firms to capture more opportunities, make faster decisions, execute efficiently, and deliver superior returns. To date, the platform has powered more than $10 trillion in transactions, partnering with hundreds of firms, including leading global institutions such as Blackstone, Nuveen, LaSalle, CBRE IM, MetLife, Newmark, Oxford Properties, New York Life, UBS, Manulife, DWS, and Principal.
Director, Strategic Finance - Corporate FP&A Cerebras SystemsDirector, Strategic Finance - Corporate FP&ASunnyvale, CAOwnership: Company-wide corporate FP&A, including owning the company model, leading long-range and annual planning, monthly forecasting, revenue forecasting, G&A budgeting, headcount, spend management, Board reporting, and public-company reporting support. KPIs and dashboards: Develop and refine KPIs, scorecards, dashboards, and analytical frameworks that highlight trends, track operating leverage, and guide leadership decisions.
Senior Director, Contracts Revolution Medicines IncSenior Director, ContractsRedwood City, CA$279,000–$321,000 / yearOther duties and responsibilities include: Partner with the Executive Director, Head of Contracting to establish the strategic direction and governance of the contracting function across the United States and EX-US, shaping enterprise contracting strategy, developing organizational capability, influencing broader Legal Operations priorities, and implementing scalable processes, playbooks, templates, and policies that support efficient contract execution from initiation through completion. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director HEOR Strategy Dermatology AbbVie IncDirector HEOR Strategy DermatologySouth San Francisco, CAThe Director, Health Economics & Outcomes Research (HEOR) leads the development & execution of projects for on-market and/or pipeline development assets, who is the brand/asset leader representing HEOR on cross functional asset/brand teams and in the pipeline commercialization teams. Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law: The compensation range described below is the range of possible base pay compensation that the Company believes in good faith it will pay for this role at the time of this posting based on the job grade for this position.
Sr. Director, Cross Border Travel Partnerships Lead Visa IncSr. Director, Cross Border Travel Partnerships LeadSan Francisco, CA$217,600–$348,300 / yearThe Global Cross Border team is responsible for defining the cross border business strategy across travel and eCommerce and managing its execution across our five regions, working closely with market teams and cross-functional leaders around the world. As a Senior Director, you will play a pivotal role in driving the growth and development of our cross border business through initiatives focused on issuers, merchants, and end-consumers that deliver cross border travel growth and value creation specifically focused on Travel.
Associate Director, Precision Medicine & Companion Diagnostics Revolution Medicines IncAssociate Director, Precision Medicine & Companion DiagnosticsRedwood City, CA$186,000–$233,000 / yearThe Opportunity: Revolution Medicines is offering a highly visible opportunity for talented and motivated individual to join our Precision Medicine Companion Diagnostics team as an Associate Director, Companion Diagnostics within the Translational Medicine function, which supports CDx development across RevMed portfolio. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Director, Processor Engagement and Solutions Visa IncDirector, Processor Engagement and SolutionsFoster City, CA$173,100–$307,600 / yearVisa is a world leader in payments technology, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories, dedicated to uplifting everyone, everywhere by being the best way to pay and be paid. As our commercial payments use cases grow with new capabilities, new verticals, and turnkey solutions, we require partnership and integration with processors and enablers in markets around the world.
Director, US Strategic Pricing, Pipeline Revolution Medicines IncDirector, US Strategic Pricing, PipelineRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Effectively partner with internal stakeholders to develop relationships to drive price strategy access including Global Market Access, Pricing, and Development, US Market Access Marketing, Field Key Account teams.
Director - Software Publisher Services - US Connor Consulting CorpDirector - Software Publisher Services - USSan Francisco, CAOur line of business is structured so that every person operates at their highest value: Directors focus on client outcomes and commercial growth, a dedicated delivery management function provides the operational infrastructure, and Account Managers and Technical Leads run day-to-day execution with genuine autonomy. What your team handles Day-to-day client communication, project management, routine budget conversations, weekly tracking, and phase management - all owned by your Account Managers and Technical Leads.
Director, Inside Sales Alation IncDirector, Inside SalesRedwood City, CA$137,493–$185,616 / yearThis is a player-coach, hands-on leadership role for someone who has built and run high-performing inside sales teams in a complex enterprise software environment, and who understands how to drive growth across both new logo acquisition and the expansion / retention of an existing customer base. Run the renewal process end-to-end in partnership with Marketing and operations - own renewal forecasts, early risk signals, on-time renewal rates, multi-year extensions, and price uplift; protect GRR and expand NRR.
Regional Insights and Engagement Director, Lung, Southeast Revolution Medicines IncRegional Insights and Engagement Director, Lung, SoutheastRedwood City, CARemote$231,000–$254,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed's US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Executive Marketing Director - Neurodegenerative (NDG) Genentech IncExecutive Marketing Director - Neurodegenerative (NDG)South San Francisco, CA$265,700–$493,400 / yearThis Executive Marketing Director (EMD) is responsible for leading the development of the inaugural Therapeutic Area and Marketing Vision for Genentech Neurodegeneration (NDG) including promising, Phase 3 assets in Alzheimer's Disease and Parkinson's Disease and driving significant changes in US Commercial/Medical/Government organization to prepare for for our first launch in the large, evolving, and competitive NDG markets. Leads and contributes to the broader 1Marketing community at Genentech, participates in initiatives that have broad functional impact or impact across multiple therapeutic areas, offers functional expertise and supports capability development for the entire Marketing function, and advances progress towards our CMG outcomes.
Director, Business Development, AI Strategic Partnerships Visa IncDirector, Business Development, AI Strategic PartnershipsSan Francisco, CA$192,300–$307,600 / yearThis role will work directly with leading AI model labs, AI platforms, infrastructure providers, developer ecosystems, and emerging technology companies to identify new opportunities for growth, product innovation, and long-term strategic advantage. Responsibilities include developing and executing commercial partnerships, influencing product strategy, identifying investment opportunities, and helping Visa understand where AI is creating meaningful new opportunities across commerce and payments.
Director, Strategic Accounts New Standard Partners LLCDirector, Strategic AccountsSanta Clara, CAAs a senior commercial leader, the Director will own executive-level client relationships, lead a multi-disciplinary team, influence cross-functional priorities, and drive long-term revenue expansion across a complex global customer base. 8+ years of experience in complex, multi-stakeholder enterprise account management, strategic sales, or commercial leadership roles supporting large IT or technology organizations.
Director, Portfolio Omnichannel (Lung HCP) Revolution MedicinesDirector, Portfolio Omnichannel (Lung HCP)Redwood City, California$211,000–$264,000 / yearThe Director, Portfolio Omnichannel Strategy & Operations (Oncology Lung HCP) is a highly collaborative leader focused on both strategy & execution and is responsible for partnering with Brand & Commercial function Leads in translating oncology brand strategies into high-impact, compliant, and innovative customer engagement experiences. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
NewDirector, Supply Chain, ERP Transformation VaxcyteDirector, Supply Chain, ERP TransformationSan Carlos, CA$219,000–$256,000 / yearIn this role, you will lead a team of process leaders in developing and executing Plan-to-Deliver capabilities-including planning, scheduling, production, quality release, and logistics-as well as overseeing the comprehensive Direct Procure-to-Pay process, including purchasing, receiving and inventory management, quality release, and reconciliation. Essential Functions: Serve as the Global Business Process Owner: Own and champion the end-to-end Plan-to-Deliver and Direct Procure-to-Pay value streams with Business Process Leaders, ensuring processes are integrated, optimized, and aligned with organizational objectives.
Associate Director, Process Validation VaxcyteAssociate Director, Process ValidationSan Carlos, CA$174,000–$203,000 / yearThe incumbent will provide leadership to ensure the organization is equipped to effectively design, execute, and communicate process validation and risk management strategies to internal stakeholders, external partners, and regulatory agencies. Director of Process Validation within the Global MSAT organization and will collaborate on overall validation strategy, with primary responsibility for process validation execution and risk management frameworks supporting commercial manufacturing.
Director, Global Supply Chain Planning AntheiaDirector, Global Supply Chain PlanningMenlo Park, CARemoteReporting to the SVP, Supply Chain & External Manufacturing, you will be a cross-functional integrator; partnering with Commercial Operations, Finance, Operations, Quality & Regulatory Affairs, and external CDMO partners to create a single version of the truth for demand and supply, and facilitating the executive decisions that keep Antheia on plan. As Director, Global Supply Chain Planning, you will be the company’s first dedicated planning leader and global S&OP process owner - architecting and operating the integrated business planning infrastructure that connects Antheia’s commercial ambitions to its manufacturing and CDMO network.
Associate Director, CMC Statistician VaxcyteAssociate Director, CMC StatisticianSan Carlos, California$170,000–$198,000 / yearThe position will be an integral part of the Vaccine Specification Working Group (VSWG), providing statistical leadership for specification setting and Justification of Specifications (JOS) across late-stage development, PPQ, BLA readiness, and commercial lifecycle management. Strong expertise in statistical methods used in CMC and analytical development, including regression, ANOVA, DOE, equivalence testing, tolerance/prediction intervals, control charts, process capability, and stability/shelf-life modeling.
Director, Product Strategy - Global SMB VisaDirector, Product Strategy - Global SMBSan Francisco, california$192,300–$307,600 / yearEstablish a regular cadence with regional product and go-to-market teams (across North America, Europe, Asia Pacific, LAC, CEMEA) to align on priorities, share market insights, and ensure that global SMB strategy is executed effectively in local markets. Visa is a world leader in payments technology, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories, dedicated to uplifting everyone, everywhere by being the best way to pay and be paid.
Director, AI Strategic Partnerships VisaDirector, AI Strategic PartnershipsSan Francisco, california$192,300–$307,600 / yearThis role will work directly with leading AI model labs, AI platforms, infrastructure providers, developer ecosystems, and emerging technology companies to identify new opportunities for growth, product innovation, and long-term strategic advantage. Responsibilities include developing and executing commercial partnerships, influencing product strategy, identifying investment opportunities, and helping Visa understand where AI is creating meaningful new opportunities across commerce and payments.
Associate Director, Process Validation and Risk Management VaxcyteAssociate Director, Process Validation and Risk ManagementSan Carlos, California$174,000–$203,000 / yearThe incumbent will provide leadership to ensure the organization is equipped to effectively design, execute, and communicate process validation and risk management strategies to internal stakeholders, external partners, and regulatory agencies. Director of Process Validation within the Global MSAT organization and will collaborate on overall validation strategy, with primary responsibility for process validation execution and risk management frameworks supporting commercial manufacturing.
Regional Insights and Engagement Director, Lung, Central Rockies Revolution MedicinesRegional Insights and Engagement Director, Lung, Central RockiesRedwood City, CaliforniaRemote$231,000–$254,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Senior Director, Head of Search & Evaluation Revolution MedicinesSenior Director, Head of Search & EvaluationRedwood City, CaliforniaRemote$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Working in close partnership with leaders across Research, Development, Commercial, Corporate Strategy, Portfolio Management, and Executive Management, this individual will lead the company's search and evaluation activities across discovery and clinical-stage opportunities.
Director, Program Management – Business Enablement AbbottDirector, Program Management – Business EnablementAlameda, California$197,300–$394,700 / yearKey projects may include (1) global website platforms for commercial and ecommerce sites (2) implementation of new AI tools that enhance customer service agent productivity and improve customer experience (3) building a roadmap that enables personalized marketing. General Medical Devices: Our medical devices help more than 10,000 people have healthier hearts, improve quality of life for thousands of people living with chronic pain and movement disorders, and liberate more than 500,000 people with diabetes from routine ngersticks.
Regional Insights and Engagement Director, Northeast Revolution MedicinesRegional Insights and Engagement Director, NortheastRedwood City, CaliforniaRemote$231,000–$254,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner with Sales, Medical Affairs, Market Access, and Commercial Operations & Business Analytics teams to ensure alignment of RevMed’s US commercialization strategy; Uncovers, prioritizes, and communicates market insights, challenges/barriers, and solutions to the organization.
Director, Strategic Planning and Business Development AbbottDirector, Strategic Planning and Business DevelopmentAlameda, California$197,300–$394,700 / yearReporting to the Division Vice President, Global Strategic Marketing, this role is responsible for identifying and executing opportunities that accelerate growth through strategic planning, portfolio optimization, partnerships, licensing, alliances, and inorganic opportunities. Develop and manage a portfolio of partnerships across digital health, automated insulin delivery, health systems, payors, EHRs, data interoperability, and adjacent technology categories.
Associate Director, Process Validation And Risk Management VaxcyteAssociate Director, Process Validation And Risk ManagementSan Carlos, CA$174,000–$203,000 / yearThe incumbent will provide leadership to ensure the organization is equipped to effectively design, execute, and communicate process validation and risk management strategies to internal stakeholders, external partners, and regulatory agencies. Director of Process Validation within the Global MSAT organization and will collaborate on overall validation strategy, with primary responsibility for process validation execution and risk management frameworks supporting commercial manufacturing.
NewAssociate Director, Revenue Accounting and Finance Revolution MedicinesAssociate Director, Revenue Accounting and FinanceRedwood City, California$186,000–$233,000 / yearPrepare and analyze monthly product revenue and gross-to-net close activities, including the calculation, recording, and monitoring of gross-to-net accruals and related reserve balances for prompt pay discounts, copay and patient assistance programs, returns, Medicaid, Medicare Part D, 340B, VA/DoD, and other forms of variable consideration. Manage the day-to-day partnership with the external government pricing consultant, including coordinating required data submissions, reviewing government pricing calculations and related outputs, and supporting accuracy and compliance across government channels, including Medicaid, Medicare Part D, 340B, and VA/FSS programs.
NewAssociate Director, Global Field Solutions Revolution MedicinesAssociate Director, Global Field SolutionsRedwood City, CaliforniaRevolution Medicines Information Sciences and Digital Innovation (ISDI) team is seeking an Associate Director, Global Field Solutions to lead the successful implementation of Commercial and Medical Go-To-Market technology solutions for field teams across new global regions, with an initial focus on Europe and Japan/Asia-Pacific. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Senior Director, Marketing Two ChairsSenior Director, MarketingSan Francisco, CA$220,000–$235,000 / yearThey will partner closely with Growth, Product, Clinical, Operations and Leadership to distill and communicate our complex value proposition, highlight the benefits of our differentiated clinical model and technology platform, strengthen our payer relationships, accelerate patient demand, and position Two Chairs as the behavioral health provider delivering on superior clinical outcomes. 7+ years of marketing leadership experience within the healthcare space, with a proven track record in B2B2C or B2B healthcare marketing (specifically targeting health plans/payers), with behavioral health experience preferred.
Director, Regulatory Affairs Companion Diagnostics CDx Revolution Medicines IncDirector, Regulatory Affairs Companion Diagnostics CDxRedwood City, CA$211,000–$264,000 / yearRequired Skills, Experience and Education: Advanced degree or bachelor's degree in life sciences, molecular biology, biomedical engineering, pharmacy, medicine, or related scientific discipline with a minimum of 12+ years of pharmaceutical, biotechnology, diagnostics, or combination product experience, including at least 8 years in Regulatory Affairs supporting companion diagnostics or in vitro diagnostics. This individual will serve as the regulatory lead for companion diagnostic development programs, partnering closely with Clinical Development, Translational Medicine, Biomarker Sciences, Regulatory Science, Commercial, and external diagnostic partners to ensure successful co-development and global registration of therapeutic products and associated companion diagnostics.
Associate Director, Medical Analytics and Exploratory Data Science Revolution Medicines IncAssociate Director, Medical Analytics and Exploratory Data ScienceRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. This role will play a critical part in the design, analysis, and interpretation of exploratory data analyses, scientific publications, real-world evidence (RWE), post-marketing research, and health economics and outcomes research (HEOR) studies.
Director, Regulatory Affairs US Filing Lead Revolution Medicines IncDirector, Regulatory Affairs US Filing LeadRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Director of Autonomy AeroVect Technologies IncDirector of AutonomySouth San Francisco, CA15+ years of hands-on experience building production autonomy systems, with strong technical depth across multiple modules (localization, perception, prediction, planning, controls). Demonstrated track record of shipping autonomy components that have run in production on real vehicles at non-trivial scale - not just research prototypes or simulation results.
Director, Regulatory Affairs Global Filing Lead Revolution Medicines IncDirector, Regulatory Affairs Global Filing LeadRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Director, Global Cross Border Issuance Strategy & Operations Visa IncDirector, Global Cross Border Issuance Strategy & OperationsSan Francisco, CA$192,300–$307,600 / yearXB Issuance Solutions: Partner with product, client services, legal, regulatory, risk, finance, technology, and regional teams to design, develop, pilot, and scale new capabilities and processes for emerging cross-border issuing models, including card programs linked to stablecoin wallets and adjacent digital-value flows. A key part of the role will be aligning senior stakeholders, translating complex issues into clear business requirements, and creating reusable processes, playbooks, and decision paths so Visa can scale Cross Border Issuance consistently across clients, regions, and use cases.
Senior Director, Molecule Global Regulatory Lead Revolution Medicines IncSenior Director, Molecule Global Regulatory LeadRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provide strategic oversight for the planning and execution of major regulatory submissions, including INDs, CTAs, amendments, expedited designation requests, marketing applications, and lifecycle submissions.
Key Account Director Comet Holding AGKey Account DirectorSan Jose, CA$280,000–$320,000 / yearAdditional responsibilities include developing strategies and execution plans with objective to increase design wins and grow market share in the RF subsystem market for the managed account while leading a team of direct and matrix members. In the Plasma Control Technologies (PCT) division, we manufacture specialized components that are required for the precise control of plasma processes and are used in the production of memory chips or touch screens for sensors, smartphones or tablets.
Sr Medical Director Hematology Clinical Development AbbVie IncSr Medical Director Hematology Clinical DevelopmentSouth San Francisco, CAActs as a clinical interface and actively solicits opinion leader interactions related to the molecule and disease area; partners with Medical Affairs, Commercial and other functions in these activities as required, consistent with corporate policies, to ensure that broad cross-functional perspectives are incorporated into Clinical Development Plans and protocols as appropriate. Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law: The compensation range described below is the range of possible base pay compensation that the Company believes in good faith it will pay for this role at the time of this posting based on the job grade for this position.
Executive Director, Global Privacy Revolution Medicines IncExecutive Director, Global PrivacyRedwood City, CAThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Reporting to the Vice President, Compliance, this role serves as a key advisor to the General Counsel (GC) and other senior executives on global privacy, data protection, and responsible data use, while fostering a culture of privacy-by-design across all business functions worldwide.